William Weldon is Chairman and Chief Executive Officer of Johnson & Johnson and is the sixth Chairman in Johnson & Johnson's over one-hundred year history.
Weldon joined J&J as a sales representative for the McNeil Pharameutical division in 1971 and eventually became the head of J&J's Ethicon Endo-Surgery business in 1992. He became the head of J&J's pharmaceutical operations in 1998 and then became J&J's CEO in 2002. As CEO, Weldon engineered some of the largest acquisitions in J&J's history including the purchase of ALZA and Pfizer's consumer-health product line.
William Weldon received a BA in Biology from Quinnipiac University.
Management for the long term...what that really is, is that we believe that there has to be a strong balance. We have to make sure that we balance our business and deliver the returns to the shareholders, but we always have to make sure we are best in the long term. We spend about $8 billion dolla...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
